Search PubMed⌕ Search

Biomedical subjects

T Mitsuma

Publications and source records attributed to T Mitsuma.

At least 343 records · Page 19Linked to original sources

Dominant IgM deposition in experimentally induced amyloid kidney of the mouse and its immunological implications.

Prolonged hyperimmmunization of C3H mice with casein resulted in immune deposits in glomeruli which led to subsequent amyloid deposition. During the immunization, the animals were in state of extreme antigen excess without any detectable circulating antibodies. The immunofluorescent findings in the later period revealed predominant IgM deposition in glomeruli, which was quite consistent with the dominant presence of IgM antibody-forming cells in spleen in the apparently tolerant state.

Amyloid↗

The effect of L-DOPA administration on thyrotropin (TSH) and thyrotropin releasing hormone (TRH) levels in serum in primary or pituitary hypothyroidism.

The effect of acute administration of L-DOPA on TSH and TRH levels in serum was studied in primary or pituitary hypothyroidism. TRH levels in serum fell and then returned to initial levels after L-DOPA administration in primary or pituitary hypothyroidism. TSH levels in serum fell and then returned to initial levels after L-DOPA administration in primary hypothyroidism. T4 and T3 levels in serum did not change after L-DOPA administration in primary or pituitary hypothyroidism. These data suggested that L-DOPA might act directly to hypothalamus.

Humans↗

[T3 toxicosis].

Explore the source record for details and available documents.

Humans↗

Antigenic competition between heterologous erythrocytes in mice. Immunological and histological studies exploring mechanisms of the antigenic competition.

To explore the mechanisms of antigenic competition, immunological and histological studies were made on mice using non-crossreacting heterologous erythrocyte antigens, i.e. sheep (SRBC), horse (HRBC) and chicken (CRBC) erythrocytes. Deficiency in the competition-inducing capacity of CRBC which we demonstrated in a previous paper was corroborated by the results that under any experimental conditions examined CRBC were unable to induce the competition. Of interest in the studies was that when anti-HRBC antibody responses of mice pre-injected with SRBC, i.e. competing antigen, were examined on day 2 and day 4 of HRBC-immunization, the day-2 response was revealed to be significantly enhanced, whereas the day-4-response was markedly suppressed as a result of the antigenic competition. By contrast, pre-injection with CRBC, i.e. non-competing antigen, did not affect at all either day-2 or day-4 anti-HRBC response of mice. Histological features of the spleens of mice either being prepared for antigenic competition or undergoing competitively suppressed antibody response were characterized by prominent regeneration of hyperplastic germinal centres, involving appearance of numerous tingible bodies and distinct collars of small lymphocytes which suggested massive proliferation and degeneration of lymphocytes. The spleens of mice in the immunological state indifferent to antigenic competition were characterized by huge lymphatic follicles which contained very few tingible bodies and were circumscribed by a markedly attenuated zone of small lymphocytes. From all these results, we suggest that massive proliferation and differentiation of T lymphocytes, probably toward regulatory (suppressor) T cells, could account for a mechanism of antigenic competition, and that deficient competition-inducing capacity of CRBC should be ascribed to weakness of their capacity in activation of the regulatory T lymphocytes.

Animals↗

[The effect of various amines on TRH contents in rat brain (author's transl)].

To study the effect of vatious amines on TRH contents in rat brain, various amines or inhibitor of synthesis of amines were injected into rat through i.v. or i.p.. Rats were decapitated and brain was frozen in dry ice and aceton. TRH contents in hypothalamus(H), cerebrum(C) and cerebellum and brain stem (C and S) were measured by TRH radioimmunoassay. TRH contents in normal rats were 3.9+/-0.5ng in H, 2.6+/-0.5NG IN C and 1.6+/-0.3ng in C and S. TRH contents in all parts of brain were increased in L-DOPA treated group and did not change in T3 or T4 treated group. TRH contents in all parts of brain were decreased in alpha-methyl-DOPA, alpha-methyl-para-tyrosine, fusaric acid and 5-HTP treated groups. In D,L-p-chlorophenylalanine treated group TRH contents in brain were increased only in hypothalamus. In L-DOPA or 5-HTP treated group with T4 or T3 preadministration, TRH contents in all parts of brain were same levels of L-DOPA or 5-HTP treated group. The above data suggested the TRH contents in rat brain were increased with increase of dopamine level in rat brain and decreased with increase of serotonine level or decrease of noradrenaline level in rat brain and inhibitory effect of T4 or T3 on TRH release might be mediated through dopaminergic and serotonergic mechanism.

5-Hydroxytryptophan↗

Radioimmunoassay of thyrotrophin releasing hormone in human serum and its clinical application.

A radioimmunoassay for thyrotrophin releasing hormone (TRH) in human serum is described. Inactivation of TRH immunoreactivity by serum is prevented by a mixture of 8-hydroxyquinoline sulphate and Tween 20. This persisted for a long period and at the concentration used in this study did not affect the TRH value. The TRH was extracted from serum with methanol. The results of the recovery experiment, dilution curve of high TRH serum, intra-assay reproducibility and inter-assay variation were quite satisfactory. The lowest detectable amount in this system was 5.0 pg/ml. Immunoreactive TRH levels in the serum were less than 60 pg/ml in normal subjects, were below the limit of detectability in hyperthyroid patients, were 40 to 400 pg/ml in primary hypothyroid patients, were 100 to 600 pg/ml in pituitary hypothyroid patients and below the limit of detectability in hypothalamic hypothyroid patients. In primary hypothyroidism, immunoreactive TRH concentrations in the serum fell to in the normal range during thyroxine substitution. In most cases of hyperthyroidism, immunoreactive TRH concentrations in the serum increased to 5.0 pg/ml or more during antithyroid drug treatment, but in a few cases the level remained below the limit of detectability even though thyroid hormone levels were in the normal range. The above data suggest that this assay system would be a useful tool to study the role of TRH in the hypothalamo-pituitary-thyroid axis.

Antibodies↗